In this photo illustration, a Boston Scientific Corporation logo seen ... [+] displayed on a smartphone and pc screen in the ...

Boston Scientific collected a set of FDA green lights for an update to its pulsed field ablation system for atrial ...

Boston Scientific received FDA approval for its navigation-enabled Farawave Nav ablation catheter and clearance for new ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Boston Scientific (BSX – Research Report) yesterday and set a price target ...

Paid and presented by Boston Scientific. Over 50% of men suffer from an enlarged prostate by age 50, but many suffer in silence through symptoms which adversely impact their quality of life.

Johnson & Johnson, Abbott and Intuitive Surgical made a mixed start to earnings season last week. The second wave of the medtech industry’s latest earnings season arrives this week, with Boston ...

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and ...

Boston Scientific has launched a docuseries campaign to remove the stigma of male incontinence. Across the videos, the campaign tells the stories of how incontinence upended the lives of three men ...

Paid and presented by Boston Scientific. With the introduction of this new remote technology in operating rooms, more people are able to go back to their active lives after a heart arrhythmia ...

TD Cowen raised the firm’s price target on Boston Scientific (BSX) to $100 from $86 and keeps a Buy rating on the shares. The firm ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Boston Scientific (BSX) reachead $86.20 at the closing of the latest trading day, reflecting a -0.58% change compared to its last close. NSPR gains premarket approval for its CGuard Prime carotid ...